C
HOWL icon

Certuity’s Werewolf Therapeutics HOWL Stock Holding History

Certuity’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.5K Hold
15,000
– – ﹤0.01% 655
2025
Q4 		$9.5K Hold
15,000
– – ﹤0.01% 585
2025
Q3 		$29.6K Hold
15,000
– – ﹤0.01% 554
2025
Q2 		$16.4K Hold
15,000
– – ﹤0.01% 423
2025
Q1 		$14.6K Hold
15,000
– – ﹤0.01% 401
2024
Q4 		$22.2K Hold
15,000
– – ﹤0.01% 377
2024
Q3 		$31.8K Buy
15,000
+5,000
+50% +$11.4K ﹤0.01% 353
2024
Q2 		$24.4K Hold
10,000
– – ﹤0.01% 352
2024
Q1 		$64.8K Hold
10,000
– – 0.01% 317
2023
Q4 		$38.6K Buy
+10,000
New +$25.5K ﹤0.01% 343

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Certuity's HOWL Position: Q1 2026 in Review

Certuity held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 15,000 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Certuity first reported a position in HOWL in Q4 2023 and has held it in 10 quarters since. The position peaked at $64.8K in Q1 2024. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Certuity held 15,000 shares of Werewolf Therapeutics worth $12.5K as of Q1 2026.
  • Certuity left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Certuity's portfolio in Q1 2026, its #655 holding.
  • Certuity first reported a position in Werewolf Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Certuity's Werewolf Therapeutics position peaked at $64.8K in Q1 2024.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.